Avation Medical pioneers wearable nerve stimulation system platforms, focusing on revolutionizing treatment for urge urinary incontinence and urinary urgency. Their flagship product, the Vivally System, offers a smart, wearable bladder control therapy combined with a mobile app, enabling patients to conduct therapy at home without the need for surgery, implants, or drugs. The company targets patients suffering from overactive bladder (OAB) syndrome, providing a non-invasive and convenient solution.
The Vivally System has made significant strides in select US geographies, offering a new standard of care for those affected by OAB. By allowing patients to manage their condition independently, Avation Medical has improved the quality of life for many individuals. The company's innovative approach has garnered attention within the medical community, positioning it as a leader in wearable medical technology.
